Ignite Creation Date:
2025-12-24 @ 3:16 PM
Ignite Modification Date:
2026-02-04 @ 11:18 PM
Study NCT ID:
NCT05832892
Status:
UNKNOWN
Last Update Posted:
2024-06-14
First Post:
2023-04-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Surufatinib Combined With KN046 and AG Regimen Chemotherapy as First-Line Treatment for Unresectable Advanced Pancreatic Cancer
Sponsor:
Shanghai Zhongshan Hospital
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Unresectable Locally Advanced or Metastatic Pancreatic Cancer | View |